바로가기메뉴

본문 바로가기 주메뉴 바로가기

Reference

1.

(2001) Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease,

2.

(2004) Standards for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper,

3.

(2004) Chronic obstructive pulmonary disease: The National Collaborating Center for Chronic Conditions national clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care,

4.

(2004) Therapeutic responses in asthma and COPD:bronchodilators,

5.

(2002) A 6-month,placebo- controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol,

6.

(2003) Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPD,

7.

(2004) The role of long-acting bronchodilators in the management of stable COPD,

8.

(1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease:a randomised controlled trial,

9.

(1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking,

10.

(2000) Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease,

11.

(2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease,

12.

(2003) Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease,

13.

(2003) Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease:a randomised controlled trial,

14.

(2003) Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease,

Tuberculosis & Respiratory Diseases